Seeking Alpha · 28 Oct 2026, 15:21 UTCSK hynix: Don't Panic Over The Immediate Threat Of CXMT's 4F Squared Efforts (NASDAQ:SKHY) | Seeking AlphaASML3.9% of IDYN
London South East · 28 Oct 2026, 11:23 UTCWRAPUP 2-European banks beat profit forecasts, Brazil overshadows SantanderBnp ParibasBNPQFUBS GroupUBSStandard CharteredSCBFF3.4% of IDYN
Seeking Alpha · 28 Oct 2026, 07:02 UTCASML: Exceptional Semiconductor Business, Expensive Valuation (NASDAQ:ASML) | Seeking AlphaASML3.9% of IDYN
wallstreet:online · 28 Oct 2026, 14:05 UTCSandoz reports strong biosimilar-sales momentum; narrowed full-year net-sales range and upgrade to margin guidanceNovartisNVS3.0% of IDYN
London South East · 28 Oct 2026, 08:18 UTCWRAPUP 1-European banks beat forecasts with third-quarter profitBnp ParibasBNPQFUBS GroupUBSStandard CharteredSCBFF3.4% of IDYN
Seeking Alpha · 28 Oct 2026, 12:00 UTCSandoz Group AG (SDZNY) Q3 2026 Sales/Trading Call Transcript | Seeking AlphaNovartisNVS3.0% of IDYN
The Manila times · 28 Oct 2026, 11:10 UTCMonte Rosa Therapeutics Announces Milestone Achievement Associated with Second Phase 2 Clinical Study Initiation for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)NovartisNVS3.0% of IDYN
Financial Times News · 28 Oct 2026, 06:29 UTCEuropean banks post higher profits in third quarterBnp ParibasBNPQFUBS GroupUBSStandard CharteredSCBFF3.4% of IDYN
The Wall Street Journal · 28 Oct 2026, 09:49 UTCSandoz Shares Fall After Company Turns Cautious on Sales GuidanceNovartisNVS3.0% of IDYN
Investing.com · 28 Oct 2026, 09:35 UTCEarnings call transcript: Sandoz narrows 2026 sales view after strong Q3 By Investing.comNovartisNVS3.0% of IDYN
Bloomberg Business · 28 Oct 2026, 09:34 UTCSandoz Warns EU May Scrap Antibiotic Protection, Risking PlantNovartisNVS3.0% of IDYN
Investing.com · 28 Oct 2026, 08:36 UTCWhy is Sandoz stock sliding today? By Investing.comNovartisNVS3.0% of IDYN
RTTNews · 28 Oct 2026, 07:56 UTCSandoz Q3 Sales Rise 4%; Cuts Annual Sales Growth Outlook, But Ups Profit Margin ViewNovartisNVS3.0% of IDYN
Yahoo! Finance · 28 Oct 2026, 07:29 UTCThe Zacks Analyst Blog Highlights Eli Lilly, Novartis, Johnson & Johnson and AbbVieNovartisNVS3.0% of IDYN
Reuters · 28 Oct 2026, 06:52 UTCGeneric drugmaker Sandoz lowers sales outlook, lifts profit forecastNovartisNVS3.0% of IDYN
Seeking Alpha · 27 Oct 2026, 19:00 UTCTech Bubble Will Pop In 2027 (undefined:ANT) | Seeking AlphaASML3.9% of IDYN
wallstreet:online · 28 Oct 2026, 12:05 UTCAstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker TestingAstrazeneca2.4% of IDYN
Seeking Alpha · 28 Oct 2026, 20:11 UTCBanco Santander, S.A. (SAN) Q3 2026 Earnings Call Transcript | Seeking AlphaBanco Santander1.8% of IDYN
The Manila times · 28 Oct 2026, 11:31 UTCMicron Biomedical Appoints Anand Subramony, Ph.D., as Executive Vice President, Global Product Development and Combination Product CommercializationAstrazeneca2.4% of IDYN